.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent nationwide registry data from Denmark suggests a significant correlation between glucocorticoids and diabetes risk. Glucocorticoids are potent anti-inflammatory agents frequently used across various medical specialties. However, their systemic effects often lead to metabolic complications, including glucose intolerance. This study investigated the dose-response association to determine how prescription intensity impacts the development of Type 2 Diabetes Mellitus (T2DM).
The research analyzed over 149,000 incident T2DM cases matched with controls between 2013 and 2021. Researchers identified a clear progressive increase in the odds of diabetes associated with higher doses of oral systemic glucocorticoids. Specifically, even at a low daily prednisolone-equivalent dose, the adjusted odds ratio (OR) was 1.25. Furthermore, the risk was not exclusive to oral administration; dermatologic applications also showed a positive correlation with incident diabetes.
Moreover, the cumulative dose played a critical role in determining the metabolic outcome. Patients with higher total exposure over a three-year period exhibited a more pronounced risk profile. Consequently, clinicians must evaluate both the duration and the potency of steroid therapy when managing patients with existing metabolic risk factors. Therefore, prioritizing the lowest effective dose for the shortest period is a vital preventive strategy.
These findings underscore the importance of metabolic monitoring for patients requiring steroid therapy. Additionally, healthcare providers should remain vigilant regarding the potential for hyperglycemia even with topical dermatologic treatments. Early screening and lifestyle interventions might mitigate some of the steroid-induced risks. Ultimately, balancing therapeutic benefits against long-term metabolic health remains a cornerstone of prudent clinical practice.
Yes, the Danish registry study indicated that both systemic and dermatologic (topical) glucocorticoid use are associated with increased odds of developing Type 2 Diabetes Mellitus in a dose-dependent manner.
The risk of developing diabetes increases progressively with higher doses of oral systemic glucocorticoids. Even low-dose prescriptions within one year of diagnosis showed a significantly higher risk compared to non-exposed individuals.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or to replace the professional judgment of a healthcare provider. Refer to the latest local and national guidelines for clinical practice.
References
Vadsholt D et al. Dose-Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case-Control Study. Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71001. PMID: 42304194.
Chowdhury S, et al. Management of steroid-induced diabetes: A review. Indian J Endocrinol Metab. 2017;21(4):587-594.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A Danish nationwide study involving over 149,000 cases shows that both systemic and dermatologic glucocorticoids are linked to an increased risk of Type 2 Diabetes in a dose-dependent manner.
last month
Researchers at Kyushu University have uncovered a novel compound, lipoic acid trisulfide (LASSS), that enhances hepatocyte growth factor (HGF) signaling and protects against nitration-induced protein dysfunction, presenting a potential breakthrough for age-related muscle atrophy and sarcopenia.
Yesterday
A study identifies a critical hypospadias gene-environment interaction. Research shows that the risk gene DNAH8 and DEHP exposure combine to disrupt steroidogenesis and mesenchymal progenitor cell differentiation, significantly increasing the risk of severe urethral malformations in male fetuses.
5 days back
A pre-clinical study reveals that elevated serum pro-N-cadherin levels correlate strongly with severe cardiac fibrosis and diastolic dysfunction following radiation exposure, promising a potential early biomarker for radiation-related heart disease.
3 days back
Discover how biophysical forces shape tissue formation and regeneration. This review explores mechanotransduction in tissue development, from molecular sensors like integrins to tissue-scale flows, highlighting critical implications for regenerative medicine and functional organoid engineering.
Last week
A groundbreaking study utilizes single-cell RNA sequencing to map the tumor microenvironment of ovarian steroid cell tumors-not otherwise specified (SCT-NOS), identifying key steroidogenic subtypes and immune cell distributions that drive hyperandrogenism and tumor progression.
Last week
